| Variables | Developed MetS | Not developed MetS | Difference (95% CI) | Mean (SE) | Mean (SE) |
| Age at registration (yr.) | 50.8 (0.34) | 50.2 (0.24) | 0.6 (−0.23, 1.43) | Duration of diabetes (yr.) | 6.2 (0.18) | 6.4 (0.13) | −0.2 (−0.62, 0.32) | Age at diagnosis (yr.) | 44.3 (0.18) | 44.0 (0.13) | 0.3 (0.00, 1.59) | Followup (yr.) | 11.6 (0.15) | 12.0 (0.11) | −0.4 (−1.13, −0.39)*** | Number of follow-up visits | 15.6 (0.41) | 9.6 (0.29) | 6.0 (5.01, 6.99)*** | Height (cm) | 159.8 (0.29) | 161.5 (0.21) | −1.7 (−2.41, −0.99)*** | Weight (kg) | 66.8 (0.36) | 64.0 (0.25) | 2.8 (1.68, 3.73)*** | BMI (Kg/m2) | 26.0 (0.12) | 24.3 (0.09) | 1.7 (1.40, 2.00)*** | Systolic BP (mmHg) | 116.1 (0.43) | 115.3 (0.31) | 0.8 (−0.30, 1.90) | Diastolic BP (mmHg) | 72.4 (0.31) | 71.6 (0.23) | 0.8 (0.00, 1.56) | Fasting glucose (mg/dL) | 203.5 (2.49) | 200.0 (1.78) | 3.5 (−2.50, 9.50) | HbA1c (%) | 8.7 (0.11) | 8.6 (0.09) | 0.1 (−0.18, 0.38) | Creatinine (mg/dL) | 0.94 (0.03) | 0.97 (0.02) | −0.03 (−0.10, 0.04) | Triglyceride (mg/dL) | 162.8 (3.77) | 158.3 (2.76) | 4.5 (−4.65, 13.70) | Cholesterol (mg/dL) | 210.7 (1.48) | 205.5 (1.07) | 5.2 (−1.61, −8.79)** | HDL cholesterol (mg/dL) | 51.0 (0.74) | 51.6 (0.68) | −0.6 (−2.58, 1.38) | LDL cholesterol (mg/dL) | 124.0 (2.44) | 121.2 (2.24) | 2.8 (−3.51, 9.51) | | % | % | | Men | 43.9 | 50.0 | −6.1 (−9.9, −2.4)** | Obesity (BMI ≥30) | 15.7 | 8.4 | 7.3 (4.7, 10.00)*** | Dyslipidemia† | 33.6 | 35.4 | −1.8 (−5.4, 1.9) | Currentsmoker | 12.9 | 19.5 | −6.6 (−9.71, −3.61)*** | Therapeutic regimen | | | | Diet | 20.7 | 23.5 | −2.8 (−5.81, 0.38) | Oral agent | 62.1 | 60.5 | 1.6 (−1.97, 5.35) | Insulin | 17.1 | 16.1 | 1.0 (−1.79, 3.84) | Education | | | | Primary or below | 64.2 | 57.6 | 6.6 (2.82, 10.30)** | Secondary | 25.4 | 28.0 | −2.6 (−5.92, 0.89) | Matriculation or above | 10.3 | 14.4 | −4.1 (−6.54, −1.57)** |
|
|